Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors

Background: Venous thromboembolism (VTE) is a life-threatening vascular event with environmental and genetic determinants. Recent VTE genome-wide association studies (GWAS) meta-analyses involved nearly 30 000 VTE cases and identified up to 40 genetic loci associated with VTE risk, including loci not previously suspected to play a role in hemostasis. The aim of our research was to expand discovery of new genetic loci associated with VTE by using cross-ancestry genomic resources. Methods: We present new cross-ancestry meta-analyzed GWAS results involving up to 81 669 VTE cases from 30 studies, with replication of novel loci in independent populations and loci characterization through in silico genomic interrogations. Results: In our genetic discovery effort that included 55 330 participants with VTE (47 822 European, 6320 African, and 1188 Hispanic ancestry), we identified 48 novel associations, of which 34 were replicated after correction for multiple testing. In our combined discovery-replication analysis (81 669 VTE participants) and ancestry-stratified meta-analyses (European, African, and Hispanic), we identified another 44 novel associations, which are new candidate VTE-associated loci requiring replication. In total, across all GWAS meta-analyses, we identified 135 independent genomic loci significantly associated with VTE risk. A genetic risk score of the significantly associated loci in Europeans identified a 6-fold increase in risk for those in the top 1% of scores compared with those with average scores. We also identified 31 novel transcript associations in transcriptome-wide association studies and 8 novel candidate genes with protein quantitative-trait locus Mendelian randomization analyses. In silico interrogations of hemostasis and hematology traits and a large phenome-wide association analysis of the 135 GWAS loci provided insights to biological pathways contributing to VTE, with some loci contributing to VTE through well-characterized coagulation pathways and others providing new data on the role of hematology traits, particularly platelet function. Many of the replicated loci are outside of known or currently hypothesized pathways to thrombosis. Conclusions: Our cross-ancestry GWAS meta-analyses identified new loci associated with VTE. These findings highlight new pathways to thrombosis and provide novel molecules that may be useful in the development of improved antithrombosis treatments.

Sebastian M. Armasu | Andrew D. Johnson | A. Reiner | J. Pankow | P. Ridker | D. Chasman | X. Jouven | E. Goode | D. Rader | B. Psaty | P. Kraft | D. Trégouët | C. Willer | K. Taylor | J. Brody | M. Germain | P. Morange | J. Hansen | R. Do | P. Natarajan | S. Braekkan | M. de Andrade | S. Damrauer | S. Heckbert | T. Bartz | F. Rosendaal | C. Kooperberg | R. Loos | K. Hveem | G. Cuéllar-Partida | Ming-Huei Chen | G. Nadkarni | R. Li-Gao | M. Teder-Laving | M. Andrade | A. Boland | J. Deleuze | P. Lutsey | N. Pankratz | J. Empana | Kaoru Ito | Wei Zhou | B. Brumpton | J. Huffman | H. M. Vy | B. Wolford | D. Klarin | R. Judy | M. Levin | J. Lynch | R. Kember | M. Sabater-Lleal | P. D. de Vries | J. Souto | J. Soria | N. Smith | K. Wiggins | R. Olaso | F. Thibord | P. Suchon | Constance Turman | A. Martinez-Perez | Xin Wang | N. Saut | S. Armasu | D. Smadja | D. Aïssi | C. Kabrhel | K. Hindberg | D. Ko | Traci M Bartz | Jennifer A. Brody | T. Nøst | Katharine R. Clapham | J. Haessler | J. Emmerich | Traci M. Bartz | V. Morelli | I. Komuro | W. Tang | S. Rich | J. Pattee | P. Morange | S. Koyama | A. Johnson | T. Gilliland | Franco Giulianini | J. Carlos Souto | C. O’Donnell | Kyung Min Lee | A. Johnson | R. Jackson | Corriene Sept | Jose Manuel Soria | A. Vlieg | Delphine Daian-Bacq | Anne Heidi Skogholt | K. Ito | H. Vy | B. Psaty | R. Loos | Christopher J. O'Donnell | N. Smith | Joseph Emmerich | K. Ito | A. Skogholt | Barbara McKnight | J. Lynch | Stephen S. Rich | Girish N. Nadkarni | X. Jouven | Alexander P. Reiner | Dylan Aïssi | Ellen L. Goode | Daian-Bacq | Kaoru Ito | Pradeep Natarajan MD MMSc | Jack W. Pattee | Li-Gao | MS MarineGermain | Darae Ko | 12 Thomas | Gilliland | Ron Do | Xin Wang | Wei Zhou | Jeffery Haessler | 14 Kristian | Hindberg | David M. Smadja | Katharine Clapham | J. F. Loos | P. Kraft | B. Psaty | Weihong Tang | John-Bjarne Hansen | C. Kabrhel | G. N. Nadkarni | David M Smadja | S. S. Rich

[1]  E. Boerwinkle,et al.  Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies , 2022, Nature Genetics.

[2]  B. Neale,et al.  Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases , 2022, medRxiv.

[3]  S. Watson,et al.  Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear , 2022, International journal of molecular sciences.

[4]  Wei Zhou,et al.  Global Biobank Meta-analysis Initiative: powering genetic discovery across human diseases , 2021, medRxiv.

[5]  J. Marchini,et al.  Exome sequencing and analysis of 454,787 UK Biobank participants , 2021, Nature.

[6]  B. Nordestgaard,et al.  α1 -antitrypsin Z allele and risk of venous thromboembolism in the general population. , 2021, Journal of thrombosis and haemostasis : JTH.

[7]  O. McCarty,et al.  Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function. , 2021, American Journal of Physiology - Cell Physiology.

[8]  G. Tamiya,et al.  ALOX12 mutation in a family with dominantly inherited bleeding diathesis , 2021, Journal of Human Genetics.

[9]  P. Morange,et al.  Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rate. , 2021, Blood.

[10]  Benjamin D. Heavner,et al.  Genome sequencing unveils a regulatory landscape of platelet reactivity , 2019, Nature Communications.

[11]  D. Garcia,et al.  Does aspirin prevent venous thromboembolism? , 2020, Hematology. American Society of Hematology. Education Program.

[12]  J. Weitz,et al.  New anticoagulants: Moving beyond the direct oral anticoagulants , 2020, Journal of thrombosis and haemostasis : JTH.

[13]  P. Wild,et al.  Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism – results from clinical observation studies , 2020, EBioMedicine.

[14]  Valeriia Haberland,et al.  The MRC IEU OpenGWAS data infrastructure , 2020, bioRxiv.

[15]  Ryan M Burke,et al.  The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function , 2020, Nature Communications.

[16]  A. Schultze,et al.  Incidence and prevalence of venous thromboembolism in Norway 2010-2017. , 2020, Thrombosis research.

[17]  Andrew D. Johnson,et al.  A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling. , 2020, American journal of human genetics.

[18]  P. Kraft,et al.  Leveraging expression from multiple tissues using sparse canonical correlation analysis and aggregate tests improve the power of transcriptome-wide association studies , 2020, bioRxiv.

[19]  D. Goldstein,et al.  Whole exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease. , 2020, Blood.

[20]  N. Mackman,et al.  Therapeutic strategies for thrombosis: new targets and approaches , 2020, Nature Reviews Drug Discovery.

[21]  Mitchell J. Machiela,et al.  LDlinkR: An R Package for Rapidly Calculating Linkage Disequilibrium Statistics in Diverse Populations , 2020, Frontiers in Genetics.

[22]  Reza Hajizadeh,et al.  Prognostic value of platelet indices in patients with acute pulmonary thromboembolism , 2020, Journal of cardiovascular and thoracic research.

[23]  William J. Astle,et al.  Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations , 2020, Cell.

[24]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[25]  Sebastian M. Armasu,et al.  Genomic and Transcriptomic Association Studies Identify 16 Novel Susceptibility Loci for Venous Thromboembolism. , 2019, Blood.

[26]  Yan V. Sun,et al.  Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease , 2019, Nature Genetics.

[27]  W. Nseir,et al.  The role of neutrophil‐lymphocyte ratio, and mean platelet volume in detecting patients with acute venous thromboembolism , 2019, Journal of clinical laboratory analysis.

[28]  Scott T. Weiss,et al.  Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations , 2019, bioRxiv.

[29]  P. Dakle,et al.  Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice , 2019, Leukemia.

[30]  D. Trégouët,et al.  Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation , 2019, Scientific Reports.

[31]  John D. Eicher,et al.  A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology. , 2019, Blood.

[32]  I. Hers,et al.  Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function , 2019, Scientific Reports.

[33]  Andrew D. Johnson,et al.  Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels , 2019, Circulation.

[34]  C. Farber,et al.  RACER: A data visualization strategy for exploring multiple genetic associations , 2018, bioRxiv.

[35]  W. Ouwehand,et al.  High-throughput elucidation of thrombus formation reveals sources of platelet function variability , 2018, Haematologica.

[36]  A. Perkins,et al.  EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription , 2018, Nature Communications.

[37]  J. Fontcuberta,et al.  Short closure time values in PFA-100® are related to venous thrombotic risk. Results from the RETROVE Study. , 2018, Thrombosis Research.

[38]  M. Frontini,et al.  Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2 , 2018, bioRxiv.

[39]  J. Staško,et al.  Association of Genetic Variability in Selected Genes in Patients With Deep Vein Thrombosis and Platelet Hyperaggregability , 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[40]  Stephen Burgess,et al.  Genomic atlas of the human plasma proteome , 2018, Nature.

[41]  L. Velazquez,et al.  The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders , 2017, Leukemia.

[42]  S. Kathiresan,et al.  Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor , 2017, Circulation. Cardiovascular genetics.

[43]  A. Morris,et al.  Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease , 2017, PLoS genetics.

[44]  R. Mägi,et al.  Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panel , 2017, European Journal of Human Genetics.

[45]  Andrew D. Johnson,et al.  Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study. , 2017, Thrombosis research.

[46]  Y. Kamatani,et al.  Overview of the BioBank Japan Project: Study design and profile , 2017, Journal of epidemiology.

[47]  A. Folsom,et al.  Genome‐wide association study with additional genetic and post‐transcriptional analyses reveals novel regulators of plasma factor XI levels , 2017, Human molecular genetics.

[48]  Luc Bressollette,et al.  Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France , 2016, Thrombosis and Haemostasis.

[49]  A. Brown,et al.  Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. , 2016, Human molecular genetics.

[50]  Mary Brophy,et al.  Million Veteran Program: A mega-biobank to study genetic influences on health and disease. , 2016, Journal of clinical epidemiology.

[51]  D. MacArthur,et al.  An eMERGE Clinical Center at Partners Personalized Medicine , 2016, Journal of personalized medicine.

[52]  Lorna M. Lopez,et al.  A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. , 2016, Human molecular genetics.

[53]  T. Lehtimäki,et al.  Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.

[54]  A. Kusiak Department of Veterans Affairs Office of Research and Development's pain portfolio. , 2016, Journal of rehabilitation research and development.

[55]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[56]  M. Hoffman Coagulation in Liver Disease , 2015, Seminars in Thrombosis & Hemostasis.

[57]  G. Kempermann Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[58]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[59]  K. Hao,et al.  Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. , 2015, American journal of human genetics.

[60]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[61]  A. Metspalu,et al.  An epidemiological perspective of personalized medicine: the Estonian experience , 2015, Journal of internal medicine.

[62]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[63]  M. Malumbres,et al.  CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. , 2015, Blood.

[64]  H. Enomoto,et al.  The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function , 2014, Nature.

[65]  T. Lehtimäki,et al.  Cardiovascular risk factors in 2011 and secular trends since 2007: The Cardiovascular Risk in Young Finns Study , 2014, Scandinavian journal of public health.

[66]  Scott M. Williams,et al.  Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2 , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[67]  Zoltán Kutalik,et al.  Quality control and conduct of genome-wide association meta-analyses , 2014, Nature Protocols.

[68]  P. Sullivan,et al.  Heritability and Genomics of Gene Expression in Peripheral Blood , 2014, Nature Genetics.

[69]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[70]  Marylyn D. Ritchie,et al.  Visualizing genomic information across chromosomes with PhenoGram , 2013, BioData Mining.

[71]  Sebastian M. Armasu,et al.  A Genome‐Wide Association Study for Venous Thromboembolism: The Extended Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium , 2013, Genetic epidemiology.

[72]  Scott M. Williams,et al.  Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. , 2012, Blood.

[73]  Sebastian M. Armasu,et al.  A genome‐wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q , 2012, Journal of thrombosis and haemostasis : JTH.

[74]  Yoav Ben-Shlomo,et al.  Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease. , 2012, American journal of human genetics.

[75]  P. Ridker,et al.  Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial , 2012, Circulation. Cardiovascular genetics.

[76]  D. Trégouët,et al.  Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project , 2012, British journal of haematology.

[77]  P. Visscher,et al.  A Better Coefficient of Determination for Genetic Profile Analysis , 2012, Genetic epidemiology.

[78]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[79]  Daniel Bilbao,et al.  FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors , 2011, The EMBO journal.

[80]  Tom Wilsgaard,et al.  Cohort profile: The Tromsø Study , 2011, International journal of epidemiology.

[81]  Jostein Holmen m.fl The Nord-Trøndelag Health Study 1995-97 (HUNT 2) , 2011 .

[82]  Mark I McCarthy,et al.  Genomic inflation factors under polygenic inheritance , 2011, European Journal of Human Genetics.

[83]  Christian Gieger,et al.  Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults , 2011, Circulation.

[84]  R. Hardison,et al.  Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes , 2011, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Schlossmann,et al.  Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation , 2011, Platelets.

[86]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[87]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[88]  S. Heath,et al.  A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism , 2010, Journal of thrombosis and haemostasis : JTH.

[89]  J. Krosl,et al.  A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. , 2010, Blood.

[90]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[91]  L. Almasy,et al.  C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. , 2010, Blood.

[92]  Andrew D. Johnson,et al.  Genome-wide meta-analyses identifies 7 loci associated with platelet aggregation in response to agonists , 2010, Nature genetics.

[93]  J. Hansen,et al.  Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study , 2010, Journal of thrombosis and haemostasis : JTH.

[94]  G. Blobel,et al.  FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment. , 2009, Blood.

[95]  J. Emmerich,et al.  Association of influenza vaccination with reduced risk of venous thromboembolism , 2009, Thrombosis and Haemostasis.

[96]  S. Heath,et al.  Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. , 2009, Blood.

[97]  P. Libby,et al.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism. , 2009, The New England journal of medicine.

[98]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[99]  J. Hansen,et al.  Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study , 2008, Journal of thrombosis and haemostasis : JTH.

[100]  P. Reitsma,et al.  Gene variants associated with deep vein thrombosis. , 2008, Journal of the American Medical Association (JAMA).

[101]  Jonghwan Kim,et al.  Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. , 2007, Molecular cell.

[102]  T. Lumley,et al.  Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. , 2007, JAMA.

[103]  M. Wilm,et al.  IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. , 2007, Blood.

[104]  S. Hankinson,et al.  Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. , 2006, Cancer research.

[105]  R. Shivdasani,et al.  Mechanisms of thrombopoiesis , 2005, Journal of thrombosis and haemostasis : JTH.

[106]  F. Rosendaal,et al.  The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality , 2005, Annals of Internal Medicine.

[107]  A. Reiner,et al.  Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. , 2004, JAMA.

[108]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[109]  Scott Davis,et al.  Implementation of the Women's Health Initiative study design. , 2003, Annals of epidemiology.

[110]  C. Overall,et al.  Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets , 2002, British journal of pharmacology.

[111]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[112]  Kiyoko Fukami,et al.  Structure, regulation, and function of phospholipase C isozymes. , 2002, Journal of biochemistry.

[113]  J. Korn,et al.  The hcKrox gene family regulates multiple extracellular matrix genes. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[114]  L. Almasy,et al.  Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. , 2000, American journal of human genetics.

[115]  L. Almasy,et al.  Genetic determinants of hemostasis phenotypes in Spanish families. , 2000, Circulation.

[116]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[117]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[118]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[119]  K. Fukase,et al.  Detection of UDP-D-Xylose:α-D-Xyloside α→3Xylosyltransferase Activity in Human Hepatoma Cell Line HepG2 , 1996 .

[120]  K. Fukase,et al.  Detection of UDP-D-xylose: alpha-D-xyloside alpha 1-->3xylosyltransferase activity in human hepatoma cell line HepG2. , 1996, Journal of Biochemistry (Tokyo).

[121]  L. Fried,et al.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.

[122]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[123]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[124]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[125]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.